BridgeMD
New treatment option for Stroke
Official title Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae
ClinicalTrials.gov ID: NCT05853952
What this study is testing
- What it's testing
- To evaluate whether NESA microcurrents can be used as an effective treatment for various sequelae present in stroke patients, specifically in the treatment of spasticity, balance, pain; and whether it affects quality of life, performance of activities of daily living and quality of sleep.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- People who have suffered a stroke with an evolution between 6 months and 6 years.
- Optimal cognitive capacity and mentally competent to participate in the study and complete the required questionnaires.
- People able of standing upright, including those who need technical aids.
You likely can't join if
- Present some of the contraindications for a treatment with NESA XSIGNAL®: pacemakers, internal bleeding, not to apply electrodes on skin in bad...
- Not having signed the informed consent form.
- Presenting any additional injury or pathology during the study.
- Not having the optimal cognitive capacities for understanding and participating in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Las Palmas de Gran Canaria, Las Palmas, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Las Palmas de Gran Canaria, Las Palmas, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.